Kevin Mcculloch serves as Executive at Xeris Biopharma Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Kevin Mcculloch has executed 5 insider transactions totaling $120.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 8, 2026 involved selling 15,000 shares valued at $120.0K.
Kevin Mcculloch currently holds 1,685,426 shares of Xeris Biopharma Holdings, Inc. (XERS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Mcculloch has been a net seller of XERS stock. They have purchased $0 and sold $120.0K worth of shares.
Kevin Mcculloch's most recent insider trade was on Jan 8, 2026, when they sold 15,000 shares at $8.00 per share.
Get notified when new Form 4 filings are submitted
| $8.31 |
| Discretionary |
| Sep 11, 2025 | XERS | $0 | Other | 2,000 | $N/A | Discretionary |
| Aug 1, 2025 | XERS | $78.8K | Payment | 14,651 | $5.38 | Discretionary |
| Aug 1, 2024 | XERS | $0 | Award | 150,000 | $N/A | Discretionary |